People who used GLP-1 medications including Ozempic, Trulicity, Wegovy, Saxenda, Victoza, Mounjaro, Rybelsus, or Zepbound and Were diagnosed with NAION vision loss, Ileus or Wernickes Encephalopathy, Required hospitalization for Gastroparesis, blocked intestine, or malnutrition Experienced Pulmonary aspiration during surgery may be eligible for compensation.
But, many have found out the hard way that when they stop taking the drug, their appetite comes roaring back
Ozempic is not FDA-approved to treat weight loss
This effect is mediated through vagal nerve pathways and direct GLP-1 receptor activation in the gastrointestinal tract
White arrows represent cells with Glp1r and Gnas dots